BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 25384085)

  • 1. Anchored multiplex PCR for targeted next-generation sequencing.
    Zheng Z; Liebers M; Zhelyazkova B; Cao Y; Panditi D; Lynch KD; Chen J; Robinson HE; Shim HS; Chmielecki J; Pao W; Engelman JA; Iafrate AJ; Le LP
    Nat Med; 2014 Dec; 20(12):1479-84. PubMed ID: 25384085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing-based identification of fusion-driven renal neoplasia: A single institution experience.
    Tekin B; Hofich CD; Pitel BA; Schoolmeester JK; Whaley RD; Raghunathan A; Ebare K; Stanton ML; Reynolds JP; Sharma V; Thompson RH; Boorjian SA; Leibovich BC; Herrera Hernandez LP; Jimenez RE; Cheville JC; Ketterling RP; Geiersbach KB; Greipp PT; Sukov WR; Kipp BR; Halling KC; Gupta S
    Hum Pathol; 2023 Dec; ():. PubMed ID: 38145826
    [No Abstract]   [Full Text] [Related]  

  • 3. Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer.
    Farago AF; Le LP; Zheng Z; Muzikansky A; Drilon A; Patel M; Bauer TM; Liu SV; Ou SH; Jackman D; Costa DB; Multani PS; Li GG; Hornby Z; Chow-Maneval E; Luo D; Lim JE; Iafrate AJ; Shaw AT
    J Thorac Oncol; 2015 Dec; 10(12):1670-4. PubMed ID: 26565381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived models of acquired resistance can identify effective drug combinations for cancer.
    Crystal AS; Shaw AT; Sequist LV; Friboulet L; Niederst MJ; Lockerman EL; Frias RL; Gainor JF; Amzallag A; Greninger P; Lee D; Kalsy A; Gomez-Caraballo M; Elamine L; Howe E; Hur W; Lifshits E; Robinson HE; Katayama R; Faber AC; Awad MM; Ramaswamy S; Mino-Kenudson M; Iafrate AJ; Benes CH; Engelman JA
    Science; 2014 Dec; 346(6216):1480-6. PubMed ID: 25394791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.
    Tsai SQ; Zheng Z; Nguyen NT; Liebers M; Topkar VV; Thapar V; Wyvekens N; Khayter C; Iafrate AJ; Le LP; Aryee MJ; Joung JK
    Nat Biotechnol; 2015 Feb; 33(2):187-197. PubMed ID: 25513782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.
    Beadling C; Wald AI; Warrick A; Neff TL; Zhong S; Nikiforov YE; Corless CL; Nikiforova MN
    J Mol Diagn; 2016 Mar; 18(2):165-75. PubMed ID: 26747586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF; Benayed R; Hyman DM; Drilon A; Zehir A; Frosina D; Arcila ME; Dogan S; Klimstra DS; Ladanyi M; Jungbluth AA
    Am J Surg Pathol; 2017 Nov; 41(11):1547-1551. PubMed ID: 28719467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.
    Sia D; Losic B; Moeini A; Cabellos L; Hao K; Revill K; Bonal D; Miltiadous O; Zhang Z; Hoshida Y; Cornella H; Castillo-Martin M; Pinyol R; Kasai Y; Roayaie S; Thung SN; Fuster J; Schwartz ME; Waxman S; Cordon-Cardo C; Schadt E; Mazzaferro V; Llovet JM
    Nat Commun; 2015 Jan; 6():6087. PubMed ID: 25608663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of cancers with NTRK gene fusions.
    Gatalica Z; Xiu J; Swensen J; Vranic S
    Mod Pathol; 2019 Jan; 32(1):147-153. PubMed ID: 30171197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mass spectrometry assay to simultaneously analyze ROS1 and RET fusion gene expression in non-small-cell lung cancer.
    Wijesinghe P; Bepler G; Bollig-Fischer A
    J Thorac Oncol; 2015 Feb; 10(2):381-6. PubMed ID: 25384172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRKing down an old oncogene in a new era of targeted therapy.
    Vaishnavi A; Le AT; Doebele RC
    Cancer Discov; 2015 Jan; 5(1):25-34. PubMed ID: 25527197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
    Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
    Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
    Zehir A; Benayed R; Shah RH; Syed A; Middha S; Kim HR; Srinivasan P; Gao J; Chakravarty D; Devlin SM; Hellmann MD; Barron DA; Schram AM; Hameed M; Dogan S; Ross DS; Hechtman JF; DeLair DF; Yao J; Mandelker DL; Cheng DT; Chandramohan R; Mohanty AS; Ptashkin RN; Jayakumaran G; Prasad M; Syed MH; Rema AB; Liu ZY; Nafa K; Borsu L; Sadowska J; Casanova J; Bacares R; Kiecka IJ; Razumova A; Son JB; Stewart L; Baldi T; Mullaney KA; Al-Ahmadie H; Vakiani E; Abeshouse AA; Penson AV; Jonsson P; Camacho N; Chang MT; Won HH; Gross BE; Kundra R; Heins ZJ; Chen HW; Phillips S; Zhang H; Wang J; Ochoa A; Wills J; Eubank M; Thomas SB; Gardos SM; Reales DN; Galle J; Durany R; Cambria R; Abida W; Cercek A; Feldman DR; Gounder MM; Hakimi AA; Harding JJ; Iyer G; Janjigian YY; Jordan EJ; Kelly CM; Lowery MA; Morris LGT; Omuro AM; Raj N; Razavi P; Shoushtari AN; Shukla N; Soumerai TE; Varghese AM; Yaeger R; Coleman J; Bochner B; Riely GJ; Saltz LB; Scher HI; Sabbatini PJ; Robson ME; Klimstra DS; Taylor BS; Baselga J; Schultz N; Hyman DM; Arcila ME; Solit DB; Ladanyi M; Berger MF
    Nat Med; 2017 Jun; 23(6):703-713. PubMed ID: 28481359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
    Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR
    Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
    Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
    Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTRK fusion-positive cancers and TRK inhibitor therapy.
    Cocco E; Scaltriti M; Drilon A
    Nat Rev Clin Oncol; 2018 Dec; 15(12):731-747. PubMed ID: 30333516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
    Drilon A; Laetsch TW; Kummar S; DuBois SG; Lassen UN; Demetri GD; Nathenson M; Doebele RC; Farago AF; Pappo AS; Turpin B; Dowlati A; Brose MS; Mascarenhas L; Federman N; Berlin J; El-Deiry WS; Baik C; Deeken J; Boni V; Nagasubramanian R; Taylor M; Rudzinski ER; Meric-Bernstam F; Sohal DPS; Ma PC; Raez LE; Hechtman JF; Benayed R; Ladanyi M; Tuch BB; Ebata K; Cruickshank S; Ku NC; Cox MC; Hawkins DS; Hong DS; Hyman DM
    N Engl J Med; 2018 Feb; 378(8):731-739. PubMed ID: 29466156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 blockade induces responses by inhibiting adaptive immune resistance.
    Tumeh PC; Harview CL; Yearley JH; Shintaku IP; Taylor EJ; Robert L; Chmielowski B; Spasic M; Henry G; Ciobanu V; West AN; Carmona M; Kivork C; Seja E; Cherry G; Gutierrez AJ; Grogan TR; Mateus C; Tomasic G; Glaspy JA; Emerson RO; Robins H; Pierce RH; Elashoff DA; Robert C; Ribas A
    Nature; 2014 Nov; 515(7528):568-71. PubMed ID: 25428505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic modifiers of EGFR dependence in non-small cell lung cancer.
    Sharifnia T; Rusu V; Piccioni F; Bagul M; Imielinski M; Cherniack AD; Pedamallu CS; Wong B; Wilson FH; Garraway LA; Altshuler D; Golub TR; Root DE; Subramanian A; Meyerson M
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18661-6. PubMed ID: 25512530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.